- Medical School - Aberdeen University (1968-1974)
- Internship - Aberdeen General Hospitals (1974-1975), General Medicine/neurosurgery
- Residency - Rochester Psychiatric Center (1975-1978), Psychiatry
- Residency - Stanford University Hospital (1978-1980), Child Psychiatry
- Residency - Stanford University Hospital (1980-1981), Child Psychiatry
Graham Emslie, M.D.
- Charles E. and Sarah M. Seay Chair in Child Psychiatry
Graham Emslie, M.D., joined the UT Southwestern faculty in 1981. He has served as Director for both the inpatient and outpatient units of Children’s Medical Center’s Psychiatry Division. Dr. Emslie's clinical focus is in child and adolescent depression.
He earned both his undergraduate degree and his medical degree at Aberdeen University in Aberdeen, Scotland. Dr. Emslie performed his internship at Aberdeen Hospitals in general medicine and neurosurgery. He then completed his residency in general psychiatry at the University of Rochester, New York, and in child psychiatry at Stanford University, where he also completed a research fellowship.
Dr. Emslie's research focus is in conducting efficacy and effectiveness trials with medications and psychotherapy for children and adolescents with depression, anxiety disorders, and attention-deficit disorders. He is also involved with developing and evaluating medication algorithm protocols for children and adolescents with depression.
Dr. Emslie is active in several professional organizations, including the American Academy of Child and Adolescent Psychiatry, the American Psychiatric Association, the Texas Society of Child and Adolescent Psychiatry, the Texas Society of Psychiatric Physicians, the Society of Biological Psychiatry, and the International Society for Research in Child and Adolescent Psychopathology. He is past President of the Texas Society of Child and Adolescent Psychiatry.
He is also on several committees, including the National Institute of Mental Health (NIMH) Interventions Committee, the NIMH Child Council Work Group, and the Corporate Contributions and Research Committee for the American Academy of Child and Adolescent Psychiatry.
Dr. Emslie has written over 60 papers and 17 chapters, and serves on the editorial board for the Journal of the American Academy of Child and Adolescent Psychiatry.
He is known internationally for his work in the treatment of pediatric depression, and in 2003, he was awarded The Klingenstein Third Generation Foundation Award for his work in the field.
- American Academy of Child and Adolescent Psychiatry
- American Psychiatric Association
- Society of Biological Psychiatry
- Texas Society of Child and Adolescent Psychiatry
- Texas Society of Psychiatric Physicians
- Klingenstein Third Generation Foundation Award for Research in Depression or Suicide 2003
- Joseph Fischhoff, M.D., Honorary Lectureship in Child and Adolescent Psychiatry. Children`s Hospital of Michigan, Detroit Medical Center/Wayne State University 2002
- Mental Health Association`s Pamela Blumenthal Memorial Prism Award 2000
- ADDA-SR Award 1996
A feasibility study of the Childhood MDD Medication Algorithm: The Texas Children`s Medication Algorithm Project (CMAP).
Emslie, GJ, Hughes CW, Crismon ML, Lopez, M, Pliszka S, Toprac, M, Boemer C. Journal of the American Academy Child and Adolescent Psychiatry 2004 43(5) 519-27
Predictors of response to treatment in children and adolescents with mood disorders.
Emslie GJ, Mayes TL, Laptook RS, Batt M. The Psychiatric clinics of North America. Depression: Recent Developments and Innovative Treatments. Rosenbaum JF, Dunner DL (eds.). W.B. Saunders Company, Philadelphia, PA 2003 435-456
Treatment for Adolescents with Depression Study (TADS): Rationale, design, and methods
Treatment for Adolescents with Depression Study Team Journal of the American Academy of Child & Adolescent Psychiatry 2003 42 531-542
Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial.
Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Neilsson M, Jacobson JG J Am Acad Child & Adolesc Psychiatry, 2002 41(10) 1205-1215
Mood disorders in children and adolescents: Psychopharmacological treatment
Emslie GJ, Mayes TL. Biol Psychiatry 2001 49 1082-1090
Fluoxetine in child and adolescent depression: Acute and maintenance treatment
Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Carmody T, Mayes TL Depression and Anxiety 1998 7 32-39
A double-blind, randomized, placebo-controlled study of fluoxetine in depressed children and adolescents
Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes, CW, Carmody T, Rintelmann JW Arch Gen Psychiatry 1997 54 1031-1037
- A feasibility study of the Childhood MDD Medication Algorithm: The Texas Children`s Medication Algorithm Project (CMAP).
- Integration of cognitive behavioral therapy (CBT) in the treatment of pediatric depression
- Pediatric depression
- Pharmacological treatment of depression in children and adolescents
- Suicidal behavior in youth
- Treatment-resistant depression